Granulocyte colony stimulating factor in patients with large acute myocardial infarction: Results of a pilot dose-escalation randomized trial

American Heart Journal

Volumn 152, Issue 6, 2006, Pages 1051.e9-1051.e14

  Ellis, Stephen G ^a   Penn, Marc S ^a   Bolwell, Brian ^a   Garcia, Mario ^a   Chacko, Matthews ^a   Wang, Thomas ^a   Brezina, Kelly J ^a   McConnell, Gerry ^a   Topol, Eric J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; GRANULOCYTE COLONY STIMULATING FACTOR; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE; HEART REINFARCTION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEM CELL; SURVIVAL;

EID: 33845221466     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.09.003     Document Type: Article

References (31)

1. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators: should we emergently revascularize occluded coronaries for cardiogenic shock?. N Engl J Med 341 (1999) 625
2. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium of autologous intracoronary mononuclear bone marrow cell transplantation of humans. Circulation 106 (2002) 1913-1918
3. Assmus B., Schachinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
4. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
5. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92-95
6. Askari A.T., Unzek S., Popovic Z.B., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (2003) 697-703
7. Henning R., Dickson A., Burgos J.D., et al. Human umbilical cord blood progenitor cells (HUCBC) are attracted to infracted myocardium and significantly reduce myocardial infarction size. Circulation 112 (2005) II-443
8. Hofmann M., Wollert K.C., Meyer G.P., et al. Monitoring of bone marrow cell homing into the infarct human myocardium. Circulation 111 (2005) 2198-2202
9. Harada J., Qin Y., Takano H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11 (2005) 305-311
10. Jackson K.A., Majka S.M., Wang H., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107 (2001) 1395-1401
11. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
12. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
13. Maekawa Y., Anzai T., Yoshikawa T., et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1510-1520
14. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarct heart, improving function and survival. Proc Natl Acad Sci U S A 98 (2001) 10344-10349
15. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards. Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
16. Garcia M.J., Thomas J.D., and Klein A.L. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 32 (1998) 865-875
17. Minatoguchi S., Takemura G., Chen X.H., et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109 (2004) 2572-2580
18. Ohtsuka M., Takano H., Zou Y., et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 18 (2004) 851-853
19. Hasegawa H., Takano H., Iwanaga K., et al. Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia. J Am Coll Cardiol 47 (2006) 842-849
20. Deindl E., Zaruba M., Brunner S., et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J 20 (2006) 956-958
21. Ince H., Petzsch M., Kleine H.D., et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 112 (2005) 3097-3106
22. Lehrke S., Mazhari R., Durand D.J., et al. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res 99 (2006) 553-560
23. Orlic D., Arai A.E., Sheikh F.H., et al. Blood 100 (2002) 94A
24. Ripa R.S., Jorgensen E., Wang Y., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction. Circulation 113 (2006) 183-192
25. Norol F., Merlet P., Isnard R., et al. Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 102 (2003) 4361-4368
26. Beohar N., Mehta J., Davidson C., et al. Dose timing dependent effects of G-CSF administration on left ventricular remodeling and global function. J Am Coll Cardiol 45 (2005) 237
27. Dimmeler S., and Vasa-Nicotera A. Aging of progenitor cells: limitation for regenerative capacity?. J Am Coll Cardiol 42 (2003) 2081-2082
28. Sheiban I., Fragasso G., Giuseppe M., et al. Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 38 (2001) 464-471
29. Fujita J., Suzuki Y., Ando K., et al. G-CSF improves post-infarction heart failure by mobilizing bone marrow stem cells, but GM-CSF increases the mortality by deteriorating heart function in mice. Circulation 106 (2002) 73
30. Hill J.M., Syed M.A., Arai A.E., et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 46 (2005) 1643-1648
31. Kang H.J., Kim H.S., and Zhang S.Y. Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 353 (2004) 751-756